Genomic Valley Biotech Ltd

Genomic Valley Biotech Ltd (GVBL) is a micro-cap Healthcare company valued at ₹10 crore operating in Biotechnology on the NSE and BSE.

Recent price move

Genomic Valley Biotech Ltd last traded at ₹32.59, down 4.99% on the day.

Financial performance

The company's business is not generating revenue or profit, with annual revenue and net profit both at ₹0 crore. Revenue and net profit have declined significantly year-over-year, with annual revenue falling -67.9% and annual net profit falling -91.7%. The latest quarter also shows no revenue or profit, with both figures remaining at ₹0 crore.

Valuation multiples

The stock trades at 325.9 times earnings, a premium to the Healthcare median of 32.0, 2.45 times book value.

Things to watch

The company has not reported any revenue or net profit for the latest fiscal year or the latest quarter. The net profit margin has fallen 30.9 percentage points to 11.3% from 42.2% in the prior year. The company's return on equity and return on capital employed are both very low, at 0.8% and 1.0% respectively.

Where it stands

The company has not generated any revenue or profit in the latest fiscal year or quarter, with both figures remaining at ₹0 crore. The net profit margin has dropped significantly to 11.3%, and return on equity and return on capital employed are both very low. The company's market cap is ₹10 crore, and its stock is 10.2% below its 52-week high.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.